FDA marketing guidelines require you login to receive more information. Please contact email@example.com for access code.
Find out if it's right for your patients.
MedCara, LLC exclusively licenses NuCara Management Group and its subsuduary pharmacies to compound WartPEEL U.S. Patent No. 7,655,668.
Practical Dermatology calls it "a Highly Effective Topical Compounded Medication for the Treatment of Cutaneous Warts."